Used in research for its potential in cancer therapy, particularly as an inhibitor of tumor angiogenesis. It targets integrin receptors on the surface of cancer cells, which play a key role in cell adhesion and signaling involved in tumor growth and metastasis. By blocking these integrins, it can suppress the formation of new blood vessels that feed tumors, thereby limiting their ability to grow and spread. Has been investigated in clinical trials for glioblastoma and other solid tumors. Also utilized in studies exploring anti-inflammatory and anti-fibrotic effects due to integrin involvement in these processes. Commonly used in laboratory settings to understand cell-matrix interactions and signaling pathways in disease models.